Marlan D. Walker, Chief Executive Officer at TherapeuticsMD, Inc. (TXMD), bought 490 shares at $1.00 ($490) on 2025-04-14, disclosed to the SEC on 2025-04-15.
Open-market purchase of $490 TXMD by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| TXMD | SELL | 2023-05-04 | $3K | — | Filing → |
| TXMD | SELL | 2023-04-14 | $4K | — | Filing → |
| TXMD | SELL | 2022-12-09 | $5K | — | Filing → |